AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
TENASCIN-C EXPRESSION IN INVASION BORDER OF EARLY BREAST-CANCER - A PREDICTOR OF LOCAL AND DISTANT RECURRENCE
Authors: JAHKOLA T TOIVONEN T VIRTANEN I VONSMITTEN K NORDLING S VONBOGUSLAWSKI K HAGLUND C NEVANLINNA H BLOMQVIST C
Citation: T. Jahkola et al., TENASCIN-C EXPRESSION IN INVASION BORDER OF EARLY BREAST-CANCER - A PREDICTOR OF LOCAL AND DISTANT RECURRENCE, European journal of cancer, 34, 1998, pp. 461-461
LEUKOCYTE NADIR AS A MARKER FOR CHEMOTHERAPY EFFICACY IN NODE-POSITIVE BREAST-CANCER TREATED WITH ADJUVANT CMF
Authors: POIKONEN P SAARTO T LUNDIN J JOENSUU H BLOMQVIST C
Citation: P. Poikonen et al., LEUKOCYTE NADIR AS A MARKER FOR CHEMOTHERAPY EFFICACY IN NODE-POSITIVE BREAST-CANCER TREATED WITH ADJUVANT CMF, European journal of cancer, 34, 1998, pp. 41-41
THE EFFECT OF WITHDRAWAL OF ADJUVANT ANTIESTROGEN THERAPY ON PLASMA-LIPID LEVELS AND BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: SAARTO T BLOMQVIST C ELOMAA I
Citation: T. Saarto et al., THE EFFECT OF WITHDRAWAL OF ADJUVANT ANTIESTROGEN THERAPY ON PLASMA-LIPID LEVELS AND BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 28-28
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGICAL FACTORS PREDICTING RESPONSE TO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER
Authors: SJOSTROM J KRAJEWSKI S FRANSSILA K NISKANEN E WASENIUS VM NORDLING S REED JC BLOMQVIST C
Citation: J. Sjostrom et al., A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGICAL FACTORS PREDICTING RESPONSE TO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER, British Journal of Cancer, 78(6), 1998, pp. 812-815
AMINOTERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN (PINP) CORRELATES TO BONE LOSS AND PREDICTS THE EFFICACY OF ANTIRESORPTIVE THERAPY IN PREMENOPAUSAL AND POSTMENOPAUSAL NONMETASTATIC BREAST-CANCER PATIENTS
Authors: SARTO T BLOMQVIST C RISTELI J RISTELI L SARNA S ELOMAA I
Citation: T. Sarto et al., AMINOTERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN (PINP) CORRELATES TO BONE LOSS AND PREDICTS THE EFFICACY OF ANTIRESORPTIVE THERAPY IN PREMENOPAUSAL AND POSTMENOPAUSAL NONMETASTATIC BREAST-CANCER PATIENTS, British Journal of Cancer, 78(2), 1998, pp. 240-245
TENASCIN-C EXPRESSION IN INVASION BORDER OF EARLY BREAST-CANCER - A PREDICTOR OF LOCAL AND DISTANT RECURRENCE
Authors: JAHKOLA T TOIVONEN T VIRTANEN I VONSMITTEN K NORDLING S VONBOGUSLAWSKI K HAGLUND C NEVANLINNA H BLOMQVIST C
Citation: T. Jahkola et al., TENASCIN-C EXPRESSION IN INVASION BORDER OF EARLY BREAST-CANCER - A PREDICTOR OF LOCAL AND DISTANT RECURRENCE, British Journal of Cancer, 78(11), 1998, pp. 1507-1513
COMPLEXITY OF 12Q13-22 AMPLICON IN LIPOSARCOMA - MICROSATELLITE REPEAT ANALYSIS
Authors: WOLF M AALTONEN LA SZYMANSKA J TARKKANEN M BLOMQVIST C BERNER JM MYKLEBOST O KNUUTILA S
Citation: M. Wolf et al., COMPLEXITY OF 12Q13-22 AMPLICON IN LIPOSARCOMA - MICROSATELLITE REPEAT ANALYSIS, Genes, chromosomes & cancer, 18(1), 1997, pp. 66-70
A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGIC FACTORS PREDICTING RESPONSETO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER
Authors: SJOSTROM J KRAJEWSKI S FRANSSILA K NISKANEN E WASENIUS VM NORDLING S REED JC BLOMQVIST C
Citation: J. Sjostrom et al., A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGIC FACTORS PREDICTING RESPONSETO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 882-882
FACTORS PREDISPOSING TO CHRONIC PAIN AFTER BREAST-CANCER-TREATMENT
Authors: TASMUTH T BLOMQVIST C VONSMITTEN K KALSO E
Citation: T. Tasmuth et al., FACTORS PREDISPOSING TO CHRONIC PAIN AFTER BREAST-CANCER-TREATMENT, European journal of cancer, 33, 1997, pp. 888-888
THE OUTCOME OF ADVANCED SOFT-TISSUE SARCOMA PATIENTS WITH COMPLETE TUMOR-REGRESSION AFTER EITHER CHEMOTHERAPY ALONE OR CHEMOTHERAPY PLUS SURGERY - THE SCANDINAVIAN SARCOMA GROUP EXPERIENCE
Authors: WIKLUND T SAETER G STRANDER H ALVEGARD T BLOMQVIST C
Citation: T. Wiklund et al., THE OUTCOME OF ADVANCED SOFT-TISSUE SARCOMA PATIENTS WITH COMPLETE TUMOR-REGRESSION AFTER EITHER CHEMOTHERAPY ALONE OR CHEMOTHERAPY PLUS SURGERY - THE SCANDINAVIAN SARCOMA GROUP EXPERIENCE, European journal of cancer, 33(3), 1997, pp. 357-361
DEMENTIA AND DRIVING - AN ATTEMPT AT CONSENSUS
Authors: LUNDBERG C JOHANSSON K BALL K BJERRE B BLOMQVIST C BRAEKHUS A BROUWER WH BYLSMA FW CARR DB ENGLUND L FRIEDLAND RP HAKAMIESBLOMQVIST L KLEMETZ G ONEILL D ODENHEIMER GL RIZZO M SCHELIN M SEIDEMAN M TALLMAN K VIITANEN M WALLER PF WINBLAD B
Citation: C. Lundberg et al., DEMENTIA AND DRIVING - AN ATTEMPT AT CONSENSUS, Alzheimer disease and associated disorders, 11(1), 1997, pp. 28-37
CHEMICAL CASTRATION-INDUCED BY ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY CAUSES RAPID BONE LOSS THAT IS REDUCED BY CLODRONATE - A RANDOMIZED STUDY IN PREMENOPAUSAL BREAST-CANCER PATIENTS
Authors: SAARTO T BLOMQVIST C VALIMAKI M MAKELA P SARNA S ELOMAA I
Citation: T. Saarto et al., CHEMICAL CASTRATION-INDUCED BY ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY CAUSES RAPID BONE LOSS THAT IS REDUCED BY CLODRONATE - A RANDOMIZED STUDY IN PREMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1341-1347
BIWEEKLY DOSE-ESCALATION IN CURATIVE ACCELERATED HYPERFRACTIONATION FOR ADVANCED HEAD AND NECK-CANCER - A FEASIBILITY STUDY
Authors: KAJANTI M BLOMQVIST C LEHTONEN H KOURI M WIKLUND T HOLSTI LR
Citation: M. Kajanti et al., BIWEEKLY DOSE-ESCALATION IN CURATIVE ACCELERATED HYPERFRACTIONATION FOR ADVANCED HEAD AND NECK-CANCER - A FEASIBILITY STUDY, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 837-840
RECURRENT GAINS OF 1Q, 8 AND 12 IN THE EWING FAMILY OF TUMORS BY COMPARATIVE GENOMIC HYBRIDIZATION
Authors: ARMENGOL G TARKKANEN M VIROLAINEN M FORUS A VALLE J BOHLING T ASKOSELJAVAARA S BLOMQVIST C ELOMAA I KARAHARJU E KIVIOJA AH SIIMES MA TUKIAINEN E CABALLIN MR MYKLEBOST O KNUUTILA S
Citation: G. Armengol et al., RECURRENT GAINS OF 1Q, 8 AND 12 IN THE EWING FAMILY OF TUMORS BY COMPARATIVE GENOMIC HYBRIDIZATION, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 351-351
TREATMENT-RELATED FACTORS PREDISPOSING TO CHRONIC PAIN IN PATIENTS WITH BREAST-CANCER - A MULTIVARIATE APPROACH
Authors: TASMUTH T KATAJA M BLOMQVIST C VONSMITTEN K KALSO E
Citation: T. Tasmuth et al., TREATMENT-RELATED FACTORS PREDISPOSING TO CHRONIC PAIN IN PATIENTS WITH BREAST-CANCER - A MULTIVARIATE APPROACH, Acta oncologica, 36(6), 1997, pp. 625-630
LONG-TERM PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR DETERMINATIONS COMPARED WITH BIOCHEMICAL RECEPTOR DETERMINATION IN PRIMARY BREAST-CANCER
Authors: BLOMQVIST C VONBOGUSLAWSKI K STENMAN UH MAENPAA H VONSMITTEN K NORDLING S
Citation: C. Blomqvist et al., LONG-TERM PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR DETERMINATIONS COMPARED WITH BIOCHEMICAL RECEPTOR DETERMINATION IN PRIMARY BREAST-CANCER, Acta oncologica, 36(5), 1997, pp. 530-532
OVERREPRESENTATION OF 1Q21-23 AND 12Q13-21 IN LIPOMA-LIKE LIPOSARCOMAS BUT NOT IN BENIGN LIPOMAS - A COMPARATIVE GENOMIC HYBRIDIZATION STUDY
Authors: SZYMANSKA J VIROLAINEN M TARKKANEN M WIKLUND T ASKOSELJAVAARA S TUKIAINEN E ELOMAA I BLOMQVIST C KNUUTILA S
Citation: J. Szymanska et al., OVERREPRESENTATION OF 1Q21-23 AND 12Q13-21 IN LIPOMA-LIKE LIPOSARCOMAS BUT NOT IN BENIGN LIPOMAS - A COMPARATIVE GENOMIC HYBRIDIZATION STUDY, Cancer genetics and cytogenetics, 99(1), 1997, pp. 14-18
BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER
Authors: MUHONEN T EEROLA H VEHMANEN P NEVANLINNA H AKTAN K BLOMQVIST C KAARIAINEN H PYRHONEN S
Citation: T. Muhonen et al., BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER, British Journal of Cancer, 76(9), 1997, pp. 1228-1231
PREDICTIVE VALUE OF C-ERBB-2, P53, CATHEPSIN-D AND HISTOLOGY OF THE PRIMARY TUMOR IN METASTATIC BREAST-CANCER
Authors: NISKANEN E BLOMQVIST C FRANSSILA K HIETANEN P WASENIUS VM
Citation: E. Niskanen et al., PREDICTIVE VALUE OF C-ERBB-2, P53, CATHEPSIN-D AND HISTOLOGY OF THE PRIMARY TUMOR IN METASTATIC BREAST-CANCER, British Journal of Cancer, 76(7), 1997, pp. 917-922
CLODRONATE IMPROVES BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH ADJUVANT ANTIESTROGENS
Authors: SAARTO T BLOMQVIST C VALIMAKI M MAKELA P SARNA S ELOMAA I
Citation: T. Saarto et al., CLODRONATE IMPROVES BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH ADJUVANT ANTIESTROGENS, British Journal of Cancer, 75(4), 1997, pp. 602-605
HEMATOLOGICAL TOXICITY - A MARKER OF ADJUVANT CHEMOTHERAPY EFFICACY IN STAGE-II AND STAGE-III BREAST-CANCER
Authors: SAARTO T BLOMQVIST C RISSANEN P AUVINEN A ELOMAA I
Citation: T. Saarto et al., HEMATOLOGICAL TOXICITY - A MARKER OF ADJUVANT CHEMOTHERAPY EFFICACY IN STAGE-II AND STAGE-III BREAST-CANCER, British Journal of Cancer, 75(2), 1997, pp. 301-305
RECURRENT GAINS OF 1Q, 8 AND 12 IN THE EWING FAMILY OF TUMORS BY COMPARATIVE GENOMIC HYBRIDIZATION
Authors: ARMENGOL G TARKKANEN M VIROLAINEN M FORUS A VALLE J BOHLING T ASKOSELJAVAARA S BLOMQVIST C ELOMAA I KARAHARJU E KIVIOJA AH SIIMES MA TUKIAINEN E CABALLIN MR MYKLEBOST O KNUUTILA S
Citation: G. Armengol et al., RECURRENT GAINS OF 1Q, 8 AND 12 IN THE EWING FAMILY OF TUMORS BY COMPARATIVE GENOMIC HYBRIDIZATION, British Journal of Cancer, 75(10), 1997, pp. 1403-1409
COMPARATIVE GENOMIC HYBRIDIZATION OF MALIGNANT FIBROUS HISTIOCYTOMA REVEALS A NOVEL PROGNOSTIC MARKER
Authors: LARRAMENDY ML TARKKANEN M BLOMQVIST C VIROLAINEN M WIKLUND T ASKOSELJAVAARA S ELOMAA I KNUUTILA S
Citation: Ml. Larramendy et al., COMPARATIVE GENOMIC HYBRIDIZATION OF MALIGNANT FIBROUS HISTIOCYTOMA REVEALS A NOVEL PROGNOSTIC MARKER, The American journal of pathology, 151(4), 1997, pp. 1153-1161
GAINS AND LOSSES OF DNA-SEQUENCES IN LIPOSARCOMAS EVALUATED BY COMPARATIVE GENOMIC HYBRIDIZATION
Authors: SZYMANSKA J TARKKANEN M WIKLUND T VIROLAINEN M BLOMQVIST C ASKOSELJAVAARA S TUKIAINEN E ELOMAA I KNUUTILA S
Citation: J. Szymanska et al., GAINS AND LOSSES OF DNA-SEQUENCES IN LIPOSARCOMAS EVALUATED BY COMPARATIVE GENOMIC HYBRIDIZATION, Genes, chromosomes & cancer, 15(2), 1996, pp. 89-94
Risultati: 1-25 | 26-50 | 51-57